Breakthrough fungal infections in patients with leukemia receiving isavuconazole

Caitlin R. Rausch, Adam J. Dipippo, Prithviraj Bose, Dimitrios P. Kontoyiannis

Research output: Contribution to journalArticlepeer-review

87 Scopus citations

Abstract

We retrospectively assessed breakthrough invasive fungal infections (b-IFIs) in 100 consecutive patients with leukemia receiving single-agent isavuconazole; 13 had documented b-IFIs (candidiasis in 6, mucormycosis in 4). All b-IFIs were observed in patients with prolonged neutropenia and active leukemia.

Original languageEnglish (US)
Pages (from-to)1610-1613
Number of pages4
JournalClinical Infectious Diseases
Volume67
Issue number10
DOIs
StatePublished - Oct 30 2018

Keywords

  • breakthrough
  • invasive fungal infections
  • isavuconazole
  • leukemia
  • neutropenia

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Breakthrough fungal infections in patients with leukemia receiving isavuconazole'. Together they form a unique fingerprint.

Cite this